Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Antibiotics research with robotics platform

Dear Sir or Madam,

many pharmaceutical companies are withdrawing from the development of antibiotics because the research is costly and new antibiotics that break resistance are usually only used as reserve antibiotics. This means that basic research has to become more attractive for the industry again. This is where a new robotics platform comes into play to simplify the development of active substances. Find out how the robotic plattform works in our interview.

Enjoy reading!

Melanie Prüser
Editorial team MEDICA-tradefair.com

PS: There are also new developments in orthopaedics with the so far unique Orthobionics degree programme in Göttingen, Germany. You can find out here how the bachelor's degree programme will qualify students for independent fitting with modern orthoses and prostheses starting in the winter semester of 2023.

Table of Contents

Interview: Robotics: modular platform for antibiotics research
Interview: Orthobionics degree program qualifies specialists
Newsletter Service
Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

Robotics: modular platform for antibiotics research

Interview – LAB & DIAGNOSTICS

Image: View of a laboratory, where a robotic facility has been built; Copyright: Anna Schroll/Leibniz-HKI
The high cost and limited commercial value of new antibiotics discourage their development, as they are used sparingly to avoid resistance. To address this, a new robotics platform aims to simplify the development of active substances to combat the problem of antibiotic resistance. While we cannot always prevent resistance, this approach offers a promising solution.
Click here for the interview
Robotics: modular platform for antibiotics research
Read all content from the experience world LAB & DIAGNOSTICS in the MEDICA Magazine here
To top

High-speed bioprinting of bones, tracheas, organs

News

LAB & DIAGNOSTICS

Developing technology to quickly and efficiently bioprint human tissues at scale is the goal of a new project led by Penn State researchers. When fully developed, the technology will be the first to enable the fabrication of scalable, native tissues such as bones, tracheas and organs.
read more
To top

Biomaterials: toolbox for the development of bioadhesives

News

DISPOSABLES

The team of Prof. Dr. Thomas Scheibel, Chair of Biomaterials at the University of Bayreuth, has compiled a current overview of the state of research on protein-based bioadhesives.
read more
To top

Orthobionics degree program qualifies specialists for orthopedics

Interview – PHYSIO TECH

Image: A man holds a prosthetic leg while a woman is screwing in it; Copyright: Marius Maasewerd, HAWK
Starting from the winter semester of 2023, the Orthobionics program will launch a distinctive bachelor's degree. Graduates will emerge as orthopedic specialists, equipped with both scientific and practical knowledge for their professional roles. Geared towards the requirements of the orthopedic technology industry, they will be adept in independently providing care with modern orthoses and prostheses.
Click here for the interview
Orthobionics degree program qualifies specialists for orthopedics
Read all content from the experience world PHYSIO TECH in the MEDICA Magazine here
To top

Epileptika: app to help treatment of epilepsy in people with intellectual disability

News

DIGITAL HEALTH

A team of researchers from the Universitat Politècnica de València (UPV) has participated in the development of Epileptika. This application aims to help the treatment of refractory epilepsy in people with intellectual disability.
read more
To top

Skin cancer diagnosis: reinforcement learning for improved performance of AI

News

DIGITAL HEALTH

An international research team led by Harald Kittler of MedUni Vienna has now explored a learning method in which greater accuracy in AI results can be achieved by incorporating human decision-making criteria.
read more
To top

AI and precision medicine may discover risk of cardiovascular disease

News

DIGITAL HEALTH

Researchers at Karolinska Institutet in Sweden, among others, have now found that artificial intelligence seems to play a role in identifying the risk of cardiovascular disease.
read more
To top

AI-based tracking and early-warning system for viral pandemics

News

DIGITAL HEALTH

Scripps Research scientists have developed a machine-learning system—a type of artificial intelligence (AI) application—that can track the detailed evolution of epidemic viruses and predict the emergence of viral variants with important new properties.
read more
To top

Cardiac disease: new technique shows cause of sleep disturbance

News

MED TECH & DEVICES

In a paper published in the journal Science, a team at the Technical University of Munich (TUM) shows that heart diseases affect the production of the sleep hormone melatonin in the pineal gland.
read more
To top

AI-based system will help people after stroke

News

PHYSIO TECH

The joint study by Rytis Maskeliūnas, a researcher at Kaunas University of Technology, Faculty of Informatics (KTU IF), and Lithuanian researchers is focused on creating an artificial intelligence (AI)-based system that aims to facilitate the rehabilitation process.
read more
To top

MED TECH & DEVICES, Company News

Fourier Intelligence Launches Advanced Rehab Robotics Centre to Expand Rehabilitation Tech Solutions in Asia

Fourier Intelligence International Pte. Ltd.

read more
Kuala Lumpur, Malaysia 28th July 2023 – A global industry leader in the rehabilitation technology industry, Fourier Intelligence recently launched its Advanced Rehab Robotics Centre in Malaysia.
To top

Buy your ticket now online!

MEDICA/COMPAMED Online Shop

Image: Ticket is being scanned at the fair entrance; Copyright: beta-web
Your advantages with the eTicket:
• Direct access on site, no waiting time.
• Registration in just a few steps already before the fair.
• You can redeem ticket vouchers directly online in the ticket shop.
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Bernhard J. Stempfle, Erhard Wienkamp

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook X LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.